- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/04 - Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
Patent holdings for IPC class A61K 38/04
Total number of patents in this class: 2180
10-year publication summary
115
|
127
|
134
|
135
|
117
|
138
|
97
|
94
|
63
|
19
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
36 |
Immatics Biotechnologies GmbH | 1144 |
31 |
Biolinerx Ltd. | 65 |
17 |
Centre National de La Recherche Scientifique | 9632 |
16 |
Children's Medical Center Corporation | 1780 |
15 |
Protagonist Therapeutics, Inc. | 124 |
15 |
The Arizona Board of Regents on Behalf of the University of Arizona | 1906 |
14 |
Biokine Therapeutics Ltd. | 53 |
14 |
Yale University | 2204 |
14 |
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1338 |
14 |
Northwestern University | 3112 |
13 |
Apellis Pharmaceuticals, Inc. | 109 |
13 |
Mondobiotech Laboratories AG | 311 |
13 |
Ipsen Pharma S.A.S. | 402 |
12 |
Ramot at Tel-Aviv University Ltd. | 1370 |
12 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
11 |
The Johns Hopkins University | 5377 |
11 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
11 |
Agency for Science, Technology and Research | 3512 |
10 |
The Board of Trustees of the University of Illinois | 2623 |
10 |
Other owners | 1878 |